secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001285550-23-000091
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro amends debt agreement to appoint PTC as collateral agent and transition to SOFR
--------------------------------------------------------------------------------

- PTC Therapeutics appointed successor collateral agent under the Securities Purchase Agreement, replacing Petrichor.
- Interest rate benchmark changed from LIBOR to Adjusted Term SOFR (2% floor + Applicable Margin) effective July 1, 2023.
- Petrichor resigns as collateral agent; all liens and security interests assigned to PTC.
- Amendment includes SOFR Conforming Changes and fallback to prime rate if Term SOFR is not determinable.
- No change to principal amount of senior secured convertible notes; rate structure updated only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000091/0001285550-23-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555023000091/clpt-20230801.htm
  HTML page:      https://secwatch.observer/filing/0001285550-23-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer